Natixis Advisors LLC Makes New $2.02 Million Investment in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Natixis Advisors LLC purchased a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the third quarter, HoldingsChannel reports. The institutional investor purchased 30,445 shares of the company’s stock, valued at approximately $2,021,000.

Several other hedge funds also recently modified their holdings of RYAN. CIBC Asset Management Inc acquired a new stake in Ryan Specialty during the third quarter worth about $231,000. Geneva Capital Management LLC lifted its position in shares of Ryan Specialty by 3.5% in the 3rd quarter. Geneva Capital Management LLC now owns 516,416 shares of the company’s stock worth $34,285,000 after acquiring an additional 17,442 shares during the period. Cumberland Partners Ltd grew its holdings in shares of Ryan Specialty by 120.0% during the 3rd quarter. Cumberland Partners Ltd now owns 22,000 shares of the company’s stock worth $1,461,000 after purchasing an additional 12,000 shares in the last quarter. Aigen Investment Management LP bought a new stake in shares of Ryan Specialty during the third quarter valued at approximately $333,000. Finally, Entropy Technologies LP acquired a new position in shares of Ryan Specialty in the third quarter valued at $369,000. 84.82% of the stock is owned by institutional investors.

Ryan Specialty Price Performance

Ryan Specialty stock opened at $74.59 on Tuesday. The business’s fifty day moving average is $69.27 and its two-hundred day moving average is $62.80. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The firm has a market cap of $19.53 billion, a P/E ratio of 96.87, a P/E/G ratio of 1.67 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $75.39.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. During the same quarter last year, the company posted $0.32 EPS. The company’s quarterly revenue was up 20.5% compared to the same quarter last year. Equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th will be given a $0.11 dividend. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a yield of 0.59%. Ryan Specialty’s payout ratio is 57.14%.

Insider Activity

In related news, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares in the company, valued at $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Nicholas Dominic Cortezi sold 5,375 shares of Ryan Specialty stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $64.73, for a total transaction of $347,923.75. Following the sale, the director now directly owns 2,685 shares of the company’s stock, valued at $173,800.05. This represents a 66.69 % decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. The Goldman Sachs Group boosted their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a report on Wednesday, October 9th. Barclays upped their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. JPMorgan Chase & Co. raised their price target on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research note on Friday, August 2nd. UBS Group upped their price objective on Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research note on Tuesday, August 13th. Finally, Wells Fargo & Company raised their target price on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $71.67.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.